2018
DOI: 10.1007/s00280-017-3507-2
|View full text |Cite
|
Sign up to set email alerts
|

Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma

Abstract: Taken together, these findings indicate that Rabd-B is a promising precursor compound that may be useful as a treatment for ESCC and thus warrants further investigation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…UEB2C directly interferes with the level of cyclin B1 protein and alters the proliferation and cell cycle characteristics of ESCC ( 66 ). Due to activation of the p53/p21 pathway, CDC25C is thus reduced, leading to cell cycle arrest ( 67 , 68 ). Although the quantity and quality of PPI data have greatly improved in recent years, the human PPI network is far from being completed.…”
Section: Discussionmentioning
confidence: 99%
“…UEB2C directly interferes with the level of cyclin B1 protein and alters the proliferation and cell cycle characteristics of ESCC ( 66 ). Due to activation of the p53/p21 pathway, CDC25C is thus reduced, leading to cell cycle arrest ( 67 , 68 ). Although the quantity and quality of PPI data have greatly improved in recent years, the human PPI network is far from being completed.…”
Section: Discussionmentioning
confidence: 99%
“…One of the least studied yet very aggressive cancers is esophageal cancer [ 31 , 32 , 33 , 34 ]. Although it is the 8th most common type of cancer, it is the 6th leading cancer in terms of cancer deaths [ 32 , 33 , 34 ]. Esophageal squamous cell carcinoma (ESCC) is the predominant histological cancer type in Africa, Asia, and Latin America.…”
Section: Introductionmentioning
confidence: 99%